🇺🇸 FDA

Intelligence · Clinical Pipeline

Autoimmune & immunology R&D Pipeline

Autoimmune, rheumatology, and immunology biologics in clinical development.

Programs
987

Quick answer

Autoimmune & immunology: NovaPharmaNews indexes 987 autoimmune & immunology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Autoimmune, rheumatology, and immunology biologics in clinical development.

Top sponsors

Page 10 of 21

  1. CTX112

    S.A.

    Warm Autoimmune Hemolytic Anemia (WAIHA)

    phase 2 mab active

    1 trial

  2. CYCLOPHOSPHAMIDE , RITUXIMAB , AB-101, FLUDARABINE

    Artiva Biotherapeutics

    Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Sjögren’s Disease (SjD)

    phase 2 small molecule active

    1 trial

  3. Ciprofloxacin

    United Therapeutics Europe Ltd

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  4. Cizutamig

    Lacuna Pharma Pty Ltd

    Severe, treatment refractory primary Sjögren’s disease (pSjD), Severe, treatment refractory idiopathic inflammatory myopathy (IIM), Severe, treatment refractory systemic sclerosis (SSc), Severe, treatment-refractory, seropositive (anti-citrullinated protein antibody (ACPA) and/or rheumatoid factor positive) rheumatoid arthritis (RA)

    phase 2 small molecule active

    1 trial

  5. DANAZOL , -, -, -, ENTECAVIR , -, VAY736

    Novartis Pharmaceuticals

    Immune thrombocytopenia (ITP) Warm autoimmune hemolytic anemia (wAIHA)

    phase 2 small molecule active

    1 trial

  6. DNTH103

    Dianthus Therapeutics, Inc. /DE/

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial

  7. Dapagliflozin 10mg Tab

    The University of Hong Kong

    Lupus Nephritis

    phase 2 small molecule active

    1 trial

  8. Daxdilimab

    Amgen

    Lupus Nephritis

    phase 2 small molecule terminated

    1 trial

  9. Delayed Release 6 mercaptopurine

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  10. Delayed Release 6MP or Calcitriol vs. Purinethol

    Teva Pharma GmbH

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  11. Descartes-08

    Cartesian Therapeutics

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule active

    1 trial

  12. Descartes-08

    Cartesian Therapeutics

    Childhood-onset Systemic Lupus Erythematous

    phase 2 small molecule active

    1 trial

  13. Descartes-08

    Cartesian Therapeutics

    Myasthenia Gravis, Generalized

    phase 2 small molecule active

    1 trial

  14. Dex 21-P

    Quince Therapeutics

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  15. Diamyd

    Wuhan Createrna Science and Technology Co., Ltd

    Latent Autoimmune Diabetes in Adults (LADA)

    phase 2 small molecule active

    1 trial

  16. Double-Blind 0.2mg CBP-307

    S.L

    Moderate to Severe Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  17. Duobrii

    Bausch & Lomb Incorporated

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  18. Dupilumab

    Regeneron UK Limited

    Colitis Ulcerative

    phase 2 small molecule active

    1 trial

  19. EP-104IAR 25 mg

    EUPRAXIA PHARMACEUTICALS INC.

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial

  20. Early recognition of progressive lung fibrosis in systemic rheumatic diseases: a characterization of the pulmonary environment through extracellular vesicles, advanced and functional imaging

    Fondazione Telethon ETS

    Patients with connective tissue diseases at high risk of interstial lung disease

    phase 2 other active

    1 trial

  21. Efavaleukin alfa

    Amgen

    Ulcerative Colitis

    phase 2 small molecule terminated

    1 trial

  22. Elsubrutinib

    AbbVie

    Systemic Lupus Erythematosus (SLE)

    phase 2 small molecule completed

    1 trial

  23. Eltrekibart

    Eli Lilly and Company

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  24. Eltrekibart, 0.9% sodium chloride, Mirikizumab, Mirikizumab, Placebo for LY3074828 SC Injection, 1mL Prefilled Syringe

    Eli Lilly Co.

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  25. Enekinragene Inzadenovec (PCRX-201)

    Pacira Ireland Limited

    Osteoarthritis (OA) of the Knee

    phase 2 mab active

    1 trial

  26. Enema transplant of fecal microbiota, Double encapsulated oral transplant of fecal microbiota

    Pari Pharma GmbH

    Ulcerative Colitis

    phase 2 small molecule active

    1 trial

  27. Enpatoran Placebo, Enpatoran

    Merck Sharp and Dohme

    Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE)

    phase 2 small molecule active

    1 trial

  28. Enpatoran low dose

    Serono Europe Limited

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  29. Enpatoran placebo, Enpatoran, Enpatoran

    Merck Sharp and Dohme

    Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE)

    phase 2 small molecule active

    1 trial

  30. Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Ulcerative Colitis or Crohn's Disease

    phase 2 small molecule active

    1 trial

  31. Etanercept

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Discoid

    phase 2 small molecule completed

    1 trial

  32. Etrasimod

    Arena Pharmaceutical Enterprises Limited

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  33. FLUDARABINE PHOSPHATE, CYCLOPHOSPHAMIDE, TOCILIZUMAB, YTB323

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus., Lupus Nephritis

    phase 2 small molecule active

    1 trial

  34. FLUDARABINE PHOSPHATE, YTB323, CYCLOPHOSPHAMIDE, TOCILIZUMAB

    Novartis Pharmaceuticals

    Difficult to treat rheumatoid arthritis, Severe, refractory Sjogren’s disease with organ involvement

    phase 2 small molecule active

    1 trial

  35. FT819

    Zafatek

    Lupus Nephritis

    phase 2 mab active

    1 trial

  36. FX005

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 2 small molecule completed

    1 trial

  37. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Shoulder

    phase 2 small molecule terminated

    1 trial

  38. FX006 10 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    2 trials

  39. FX006 32 mg

    Pacira Ireland Limited

    Post-traumatic Osteoarthritis of the Knee

    phase 2 small molecule terminated

    1 trial

  40. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Shoulder

    phase 2 small molecule completed

    1 trial

  41. FX006 32 mg

    Pacira Ireland Limited

    Bilateral Knee Osteoarthritis

    phase 2 small molecule completed

    1 trial

  42. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 2 small molecule completed

    1 trial

  43. Filgotinib

    Lakefront Biotherapeutics NV

    Fistulizing Crohn's Disease

    phase 2 small molecule completed

    1 trial

  44. Filgotinib

    Lakefront Biotherapeutics NV

    Small Bowel Crohn's Disease

    phase 2 small molecule completed

    1 trial

  45. Fostamatinib

    AstraZeneca

    Rheumatoid Arthritis

    phase 2 small molecule terminated

    1 trial

  46. Fostamatinib 150 mg bid

    RIGEL PHARMACEUTICALS INC

    Warm Antibody Autoimmune Hemolytic Anemia

    phase 2 small molecule completed

    1 trial

  47. Fostamatinib Disodium (R935788)

    RIGEL PHARMACEUTICALS INC

    Systemic Lupus Erythematosus

    phase 2 small molecule terminated

    1 trial

  48. Fostamatinib disodium (R935788)

    RIGEL PHARMACEUTICALS INC

    Rheumatoid Arthritis

    phase 2 small molecule completed

    2 trials

Frequently asked questions

How many autoimmune & immunology pipeline programs are tracked?

987 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.